Background: Ca 2؉ loading occurs during myocardial reperfusion injury. Volatile anesthetics can reduce reperfusion injury. The authors tested whether sevoflurane administered before index ischemia in isolated hearts reduces myoplasmic diastolic and systolic [Ca 2؉ ] and improves function more so than when sevoflurane is administered on reperfusion.
REPERFUSION after cardiac ischemia can cause reversible mechanical dysfunction (stunning) or cell death (infarction) depending on the duration and magnitude of ischemia. 1 Myoplasmic Ca 2ϩ overload during ischemia, and particularly on reperfusion, contributes to the injury. [2] [3] [4] [5] [6] Ca 2ϩ loading is due largely to intracellular acidosis and a large transmembrane pH gradient that promotes Na ϩ -H ϩ exchange and, in turn, reverse-mode Na ϩ -Ca ϩ exchange at the onset of reperfusion. [2] [3] [4] Impaired adenosine triphosphate synthesis on reperfusion results from cytoskeletal damage by reactive oxygen (O 2 ) species and mitochondrial Ca 2ϩ overload. [7] [8] [9] These effects can cause hypercontracture and incomplete relaxation of myofibrils or cell death. 1, 9 It has long been known that administering a volatile anesthetic before ischemia, or before and after hypoxia or ischemia, improves cardiac function and reduces the occurrence of dysrhythmias on reperfusion. 10 -14 This was thought to arise from a metabolic sparing effect or from inhibition of Ca 2ϩ influx by the anesthetic. It was discovered earlier that hearts can be protected by "preconditioning" before ischemia, i.e., by brief pulses of ischemia before prolonged ischemia. 15 Protection was assessed by reduced infarct size, attenuated mechanical dysfunction, or limited ultrastructural abnormality. More recently, anesthetics have also been shown to precondition hearts against ischemia. 16 -21 We have shown that sevoflurane preconditioning mimics ischemic preconditioning by improving vascular, mechanical, and metabolic function and induced endothelial nitric oxide release in guinea pig hearts. 17, 18 Because these effects were blocked by glibenclamide, the ATP-sensitive potassium channel (K ATP ) opening has an important role in mediating the protective effect. 18 We also reported recently that anesthetic preconditioning, like ischemic preconditioning, reduces Ca 2ϩ loading and improving function on reperfusion 21 ; this indicates an important link between cardiac function and Ca 2ϩ homeostasis during both ischemic and anesthetic preconditioning.
We questioned whether treatment with a volatile anesthetic before ischemia protects hearts better than treatment on initial reperfusion. We proposed that protection obtained by the former treatment was triggered or mediated by depressed cardiac metabolism and effected by reduced myoplasmic Ca 2ϩ loading on reperfusion; protection afforded by the latter treatment was due to a direct metabolic sparing effect mediated only on reperfusion that reduced Ca 2ϩ loading. To test this, we administered sevoflurane before and/or after global ischemia in isolated hearts and examined the changes in mechanical, metabolic, and vascular function associated with myoplasmic systolic and diastolic [Ca 2ϩ ] on reperfusion.
Materials and Methods

Langendorff Heart Preparation
The investigation conformed to the Guide for the Care and Use of Laboratory Animals (US National Institutes of Health No. 85-23, revised 1996). Approval was obtained previously from the Medical College of Wisconsin animal studies committee (Milwaukee, WI). Portions of our methods have been described in detail previously. 5, 6, [21] [22] [23] [24] [25] Sixty guinea pig hearts were isolated and perfused with a modified Krebs-Ringer's solution 6, 21, 24, 25 and perfused at an aortic root perfusion pressure of 55 mmHg at 37.3 Ϯ 0.1°C. Left ventricular pressure (LVP) was measured isovolumetrically, and right atrial and ventricular electrograms were recorded to monitor spontaneous heart rate (HR) and atrioventricular conduction time. [21] [22] [23] [24] [25] Coronary flow (CF) was measured at the aorta, and coronary sinus venous partial pressure of oxygen (PO 2 ) tension was measured continuously online with an O 2 Clark-type electrode. Percent O 2 extraction was calculated as 100 · (PO 2 a Ϫ PO 2 v)/PO 2 a, myocardial O 2 consumption (MvO 2 ) was calculated as CF/g · (PO 2 a Ϫ PO 2 v) · 24 l O 2 /ml at 760 mmHg, and cardiac work efficiency was calculated as systolic-diastolic LVP · HR/MvO 2 .
Measurement of Cytosolic and Noncytosolic Free Ca 2ϩ in Intact Hearts
Loading Fluorescent Probe Indo-1 and Recording Ca 2؉ Transients. We have published this methodology in detail. 5, 6, 21, 22, 24, 25 Experiments were performed in a light-blocking Faraday cage. The heart was partially immobilized by hanging it from the aortic cannula, the pulmonary artery catheter, and the left ventricular balloon catheter. The heart was immersed in a bath. The distal end of a trifurcated fiber silica fiberoptic cable (optical surface area 3.85 mm 2 ) was placed against the left ventricular epicardial surface through a hole in the bath. A rubber O ring was placed between the ferrule and the heart to reduce cardiac motion at the contact point of the fiberoptic tip. Background autofluorescence was determined for each heart after initial perfusion and equilibration at 37°C. Thereafter, hearts were loaded with indo-1 acetoxymethyl ester (AM) at room temperature (25 Ϯ 0.6°C) for 20 -30 min with 165 ml recirculated Krebs-Ringer's solution containing 6 M indo-1 AM (Sigma Chemical, St. Louis, MO). Indo-1 AM was initially dissolved in 1 ml dimethyl sulfoxide containing 16% (weight/volume) Pluronic I-127 (Sigma Chemical) and was diluted to 165 ml with modified Krebs-Ringer's solution. Loading was stopped when the F 385 intensity was increased 10-fold. Residual indo-1 AM was washed out by perfusing the heart with standard perfusate for at least another 20 min, and then each heart was rewarmed to 37.2 Ϯ 0.1°C before initiating the study. The perfusate contained probenecid (100 M) to retard leakage of indo-1. Loading and washout of indo-1 reduces LVP approximately 25%, an effect due to the vehicle and to intracellular Ca 2ϩ buffering by indo-1 per se. 6, 22, 24 Fluorescence emissions at F 385 and F 456 were recorded using a modified luminescence spectrophotometer (SLM Aminco-Bowman II; Spectronic Instruments, Urbana, IL). The left ventricular region of the heart was excited with light from a xenon arc lamp, and the light was filtered through a 355-nm monochromator with a bandwidth of 8 nm. The beam was focused onto the in-going fibers of the optic bundle. The arc lamp shutter was only opened for 2.5-s recording intervals. Fluorescence emissions were collected by fibers of the remaining two limbs of the cable and filtered by square interference filters (Corion, Franklin, MA) at 385 (390 Ϯ 5) and 456 (460 Ϯ 5) nm.
An advantage of the indo-1 ratiometric procedure is that although both F 385 and F 456 decrease over time, the F 385 /F 456 ratio remains stable during the experimental period. 6 In companion studies, tissue autofluorescence was measured throughout each experiment in the absence of ischemia (autofluorescence control, n ϭ 8) and before, during, and after ischemia (ischemia control, n ϭ 8). The mean F 385 and F 456 background values obtained were then subtracted from the corresponding F 385 and F 456 values from the indo-1-treated hearts at the same time point and for the same experimental condition.
Calculation of Cytosolic and Noncytosolic Ca 2؉ Concentrations from F 385 /F 456 Transients. The Ca 2ϩ transient obtained from the indo-1 fluorescence ratio F 385 /F 456 is proportional in a nonlinear manner to [Ca 2ϩ ]. Calibration curves were derived according to previously published protocols by Brandes et al. 26, 27 using modifications of a standard equation for fluorescent indicators. 28 (1) where S ϭ ratio of light intensities (I) at the same wavelength at min and max Ca 2ϩ , S r ϭ (1 Ϫ S 456 )/(1 Ϫ S 385 ) ϭ Ϫ1.48, and bH ϭ the average slope (b) of tot F 385 as a function of tot F 456 ϭ Ϫ0. 25 .
We calculated the dissociation constant (K d ) of indo-1 using homogenized guinea pig heart protein as 249 Ϯ 8 nM at 37°C. 24 R max was calculated as 5.986, and R min was calculated as 0.059.
Non cytosolic (primarily mitochondrial) mito [Ca 2ϩ ] was calculated similarly:
where mito R was calculated as the ratio of the noncytosolic fluorescence, mito F 385 , and mito F 456 , respectively. Noncytosolic fluorescence was measured at the end of each experiment (185 min) in control (CON; n ϭ 8), sevoflurane before ischemia (SBI; n ϭ 7), sevoflurane before and after ischemia (SBAI; n ϭ 9), and sevoflurane after ischemia (SAI; n ϭ 7) groups after perfusing hearts with 100 M MnCl 2 for 10 min to quench fluorescence derived from the cytosolic (cyto) compartment. 6, 27 mito F 385 and mito F 456 were calculated at each time point by multiplying the residual mitochondrial fluorescence fractions (f 385 and f 456 ) by total end-diastolic fluorescence so that:
Similar to equations 1 and 2, cytosolic cyto [Ca 2ϩ ] was calculated as: 
Protocol
There were four primary groups subjected to ischemia reperfusion; each experiment lasted 195 min beginning after 30 min equilibration. An untreated time control group (n ϭ 9) was not subjected to ischemia; these data are not plotted. The four ischemia groups underwent 30 min of fluorescent dye loading, 20 min of washout, and 45 min of equilibration; this was followed by 30 min of global, no-flow ischemia, 60 min of reperfusion, and 10 min of Mn 2ϩ quenching. During ischemia, hearts were immersed in a bath of Krebs-Ringer's solution at 37.3 Ϯ 0.3°C. The SBI group had 85 min of perfusion followed by a 10-min exposure to 3.5 vol% sevoflurane immediately before 30 min of ischemia. The SAI group had 95 min of perfusion, 30 min of ischemia, and 60 min reperfusion, with exposure to 3.5 vol% sevoflurane only during the first 10 min of reperfusion. Hearts of the SBAI group were exposed to 3.5 vol% sevoflurane for 10 min just before 30 min ischemia and also immediately during the first 10 min of reperfusion. If ventricular fibrillation occurred, a 0.25-ml bolus of lidocaine (250 g) was administered immediately via the aortic cannula. All hearts reverted to sinus rhythm, and data were collected after stabilization of LVP. Sevoflurane was bubbled into the perfusate using an agent-specific vaporizer placed in the oxygen-carbon dioxide gas mixture line. Coronary effluent was collected anaerobically from the aortic cannula to measure sevoflurane concentration by gas chromatography. [12] [13] [14] 17, 18 Inflow concentrations (in mM) were 0.62 Ϯ 0.04 for SBI, 0.66 Ϯ 0.04 for SAI, and 0.63 Ϯ 0.05 and 0.67 Ϯ 0.03 for SBAI, which combined was equivalent to 3.34 Ϯ 0.28 vol% atmospheres for a minimal alveolar concentration (MAC of sevoflurane ϭ 2.4%) of approximately 1.52 Ϯ 0.2%. Sevoflurane was not detectable in the effluent during the initial equilibration period, the onset of the reperfusion period (CON and SBI groups), or from 15 to 60 min of reperfusion (all groups).
Data Presentation and Interpretation
Cytosolic Systolic and Diastolic Ca 2؉ . Initial measurements obtained throughout fluorescence dye loading and vehicle washout are not displayed; results shown in graphs begin at 50 min before ischemia. Mechanical, metabolic, and F 385 and F 456 measurements were made at 1-to 30-min intervals throughout the study. F 385 , F 456 , and F 385 /F 456 Ca 2ϩ transient signals, LVP, and dLVP/dt were displayed simultaneously on a computer screen and stored digitally using proprietary software (SLM Aminco-Bowman II, series 2, on OS/2 version 3, International Business Machines Corp., Thornwood, NY). After correcting for tissue autofluorescence over time, with or without ischemia and reperfusion, and quenching cytosolic (myoplasmic) compartment Ca 2ϩ to reveal noncytosolic compartment Ca 2ϩ , the signals were calibrated to nM [Ca 2ϩ ] using algorithms developed by our group. LVP and raw metabolic data were recorded (MacLab; AD Instruments, Castle Hills, Australia) and, together with the Ca 2ϩ transient data, were later analyzed together (Microsoft Excel ® ; Microsoft Corp., Redmond, WA). Several characteristics of myoplasmic [Ca 2ϩ ] were analyzed: peak systolic, peak diastolic, and phasic systolic-diastolic [Ca 2ϩ ], i.e., released or phasic [Ca 2ϩ ]; mitochondrial (noncytosolic) [Ca 2ϩ ], measured at the end of each experiment, is not phasic. Characteristics of LVP analyzed were systolic, diastolic, and systolic-diastolic LVP, and dLVP/dt max and dLVP/dt min .
Statistical Analysis
All data were expressed as mean Ϯ standard error of the mean (SEM), and a P value (two-tailed) less than 0.05 was considered significant. Within-group data over time at specific times (88,124,128, and 181 min) for a given variable were compared with a pretreatment control period (at 78 min) by the Duncan comparison of means test whenever univariate analysis of variance fluorescence values for repeated measures were significant (P Ͻ 0.05; Super ANOVA 1.11 ® software for Macintosh ® from Abacus Concepts, Inc., Berkeley, CA). Amonggroup data were analyzed at specific time points before (at 78 min) and after (at 88,124, 128, and 181 min) ischemia using multiple analysis of variance (Super ANOVA ® ). If fluorescence values were significant, post hoc comparisons of means were performed using the Student t test with Duncan adjustment for multiplicity to differentiate among the four analyzed treatment groups. The incidence of ventricular fibrillation versus sinus rhythm per group and the number of ventricular fibrillations per heart per group were determined by Fisher exact test. Differences in ventricular fibrillation duration were determined by unpaired t tests. Some among-group statistical notations that are not given in the figures are given in the text. Within-group comparisons on reperfusion versus before ischemia are given only in the text.
Results
In the time control group, no measured mechanical or metabolic variable changed over 180 min perfusion; systolic [Ca 2ϩ ] and diastolic [Ca 2ϩ ] also did not change. Variables unchanged (not significant) at 60 min of reperfusion from 50 min before ischemia and averaged for all ischemia groups, were HR, 254 Ϯ 3 to 251 Ϯ 3 beats/min, and atrioventricular conduction time, 76 Ϯ 2 to 77 Ϯ 2 ms. Venous pH values for CON, SBI, SBAI, and SAI groups, respectively, were not different before ischemia, 7.16 Ϯ 0.03, 7.12 Ϯ 0.03, 7.12 Ϯ 0.04, and 7.11 Ϯ 0.05, and were not different at 60 min of reperfusion, 7.09 Ϯ 0.05, 7.08 Ϯ 0.06, 7.09 Ϯ 0.04, and 7.08 Ϯ 0.05. Ventricular fibrillation was the most notable dysrhythmia observed on reperfusion. The percentage of hearts that fibrillated during reperfusion was 100% for CON, 72% for SBI , 92% for SBAI, and 89% for SAI (P Ͼ 0.05). The median number of fibrillations per heart was 3.0 for CON, 1.0 for SBI, 1.0 for SBAI, and 1.0 for SAI; this number was lower (P Ͻ 0.05) in SBI, SAI, and SBAI groups than in the CON group. Figures 1A-6B display the associated temporal changes in cytosolic [Ca 2ϩ ] and cardiac function at 25 time points beginning 45 min before the onset of 30-min ischemia and 60-min reperfusion. Systolic [Ca 2ϩ ] decreased slowly over 10 min during ischemia and then increased abruptly twofold during initial reperfusion in the CON group (fig. 1A) . The increase in systolic [Ca 2ϩ ] on 1 min reperfusion was much less in SBI, SAI, and SBAI groups and returned to control levels after 5 min in each treated group but only after 15 min of reperfusion in CON. Systolic LVP decreased faster than systolic [Ca 2ϩ ] during early ischemia ( fig. 1B ) and began to increase after 25 min of ischemia. Systolic LVP increased on initial reperfusion to the control level in SBI and SBAI groups, but not in SAI and CON groups; moreover, systolic LVP remained higher in the SBI group than in the SAI group for the first 30 min of reperfusion. Diastolic [Ca 2ϩ ] increased progressively twofold during ischemia and up to fourfold during initial reperfusion in each group ( fig.  2A) ; diastolic [Ca 2ϩ ] remained increased up to 30 min in CON but returned faster toward controls in sevofluranetreated groups. Diastolic LVP ( fig. 2B ) increased in each group during the last 5 min of ischemia. During reperfusion, diastolic LVP increased less in SBI, SBAI, and SAI groups compared with CON and remained above the ] increased maximally on initial reperfusion, whereas systolic LVP remained reduced throughout reperfusion in CON and SAI groups but recovered in SBI and SBAI groups. CON ‫؍‬ control, no treatment before 30 min global ischemia and 60 min reperfusion (n ‫؍‬ 8); SBI ‫؍‬ 3.5 vol% sevoflurane administered 10 min before ischemia (n ‫؍‬ 7); SAI ‫؍‬ 3.5 vol% sevoflurane administered 10 min after ischemia (n ‫؍‬ 7); SBAI ‫؍‬ 3.5 vol% sevoflurane administered 10 min before and after ischemia (n ‫؍‬ 9). Comparisons among and within groups were determined at specific time points before ischemia (at 78 and 88 min) and on reperfusion (at 124, 128, and 181 min). control level only in CON and SAI groups at 60 min of reperfusion.
Systolic-diastolic [Ca 2ϩ ], i.e., phasic [Ca 2ϩ ], ( fig. 3A ) decreased slowly over 10 min in all groups during initial ischemia, after which the transients disappeared until reperfusion. Systolic-diastolic [Ca 2ϩ ] increased abruptly approximately twofold during the first minute of reperfusion in CON but less so in sevoflurane-treated groups and remained higher during reperfusion in CON compared with the SBI and SAI groups. Unlike phasic [Ca 2ϩ ], developed systolic-diastolic LVP ( fig. 3B ) decreased abruptly to near zero at the onset of ischemia. At 5 min of reperfusion, systolic-diastolic LVP was decreased by 66% in CON, whereas it was reduced approximately 41% averaged for all sevoflurane-treated groups. Between 20 and 60 min of reperfusion, systolic-diastolic LVP was higher in SBI and SBAI than in CON and SAI groups and higher in SAI than in CON.
Contractility, dLVP/dt max ( fig. 4A ), was decreased moderately during SBI and SBAI treatments and approached zero in each group during ischemia; dLVP/dt max was decreased by 70% on initial reperfusion in CON and by approximately 34% averaged for the sevoflurane-treated groups. dLVP/dt max remained depressed at 60 min reperfusion in the CON and SAI groups, but not in the SBI and SBAI groups. Relaxation, dLVP/dt min (fig. 4B ), exhibited trends for each group similar to those of dLVP/dt max .
Coronary flow ( fig. 5A ) was not altered by sevoflurane in SBI and SBAI groups before ischemia. Coronary flow at 60 min of reperfusion remained lower than before ischemia in each group but was higher in each sevoflurane-treated group. MvO 2 (fig. 5B ) was indeterminate during ischemia and was lower in all groups but the SBI group on initial reperfusion and was higher in each sevoflurane group after 20 min of reperfusion compared with the CON group. Among the sevoflurane groups, figure 1 for details on groups and statistics.
Fig. 3. Time course of phasic (systolic-diastolic [sys-dia]) [Ca 2؉ ] (A) and systolic-diastolic left ventricular pressure (LVP) (B) before, during, and after global ischemia in CON, SBI, SBAI, and SAI groups. Note that systolic-diastolic [Ca 2؉ ] decreased during ischemia in all groups and increased approximately twofold during initial reperfusion in the CON group, but that the increase was smaller in each sevoflurane (SEV) group. Phasic LVP was higher in each sevoflurane group on reperfusion and was especially higher in the SBI and SBAI groups up to 60 min of reperfusion. See
Fig. 2. Time course of diastolic (dia) [Ca 2؉ ] (A) and diastolic left ventricular pressure (LVP) (B) before, during, and after global ischemia in CON, SBI, SBAI, and SAI groups. Note that diastolic [Ca 2؉ ] increased gradually and similarly by twofold in all groups during ischemia and increased additionally during reperfusion. Diastolic LVP increased similarly during late ischemia and increased markedly during reperfusion in all groups. Diastolic LVP was lower in the SAI group than in the CON group throughout reperfusion and was lowest in SBI and SBAI groups. See figure 1 for details on groups and statistics. SEV ‫؍‬ sevoflurane.
MvO 2 was highest on final reperfusion in the SBI and SBAI groups and lowest in the SAI group.
Cardiac work efficiency ( fig. 6A ) was not altered by sevoflurane in SBI and SBAI groups before ischemia among the groups. On reperfusion, cardiac efficiency was higher in all sevoflurane groups and especially in the SBI and SBAI group; it remained decreased at 60 min of reperfusion only in CON. Percent O 2 extraction ( fig. 6B ) was reduced by sevoflurane in SBI and SBAI groups before ischemia; on reperfusion, it was lower in all sevoflurane-treated groups compared with CON.
Discussion
We examined cardioprotective effects of a volatile anesthetic, sevoflurane, administered for 10 min immediately before global ischemia, for 10 min on reperfusion immediately after ischemia, and both before and after ischemia to ascertain whether the timing of exposure to the anesthetic influences the extent of protection. At the same time, we measured whether diastolic and systolic myocyte [Ca 2ϩ ] during ischemia and reperfusion are modulated by the protective effect of the anesthetic when administered before or after ischemia. As in previous studies using other volatile anesthetics, we observed that sevoflurane treatment afforded cardioprotection by reducing dysrhythmias and improving mechanical and metabolic function. Concomitantly, we observed that improved function with each sevoflurane treatment was associated with reduced systolic and phasic Ca 2ϩ loading on reperfusion.
It was interesting that sevoflurane administered before ischemia was more protective than sevoflurane administered on reperfusion. One might expect that because it is during the reperfusion period that the major damage to cells occurs, administering a depressant agent during reperfusion would be more protective that when administered before ischemia. Sevoflurane administered before ischemia exerted minimal cardiac effects except for small decreases in contractility (dLVP/dt max ), relaxation (dLVP/dt min ), and percent O 2 extraction. However, this small metabolic sparing effect before ischemia could trigger mechanisms that lead to cardioprotection on
Fig. 5. Time course of coronary flow (A) and myocardial oxygen consumption (MvO 2 ;
l O 2 · g ؊1 · min ؊1 ) (B) before, during, and after global ischemia in CON, SBI, SBAI, and SAI groups. Note that coronary flow and MvO 2 were higher in each sevoflurane (SEV) treatment group throughout reperfusion compared with the CON group and were higher in the SBI and SBAI groups than in the SAI group. See figure 1 for details on groups and statistics.   Fig. 4 . Time course of dLVP/dt max (A) and dLVP/dt min (B) before, during, and after global ischemia in CON, SBI, SBAI, and SAI groups. Note that sevoflurane (SEV) treatment in SBI and SBAI groups slightly decreased dLVP/dt max and dLVP/dt min such that dLVP/dt max and dLVP/dt min were moderately decreased during reperfusion but that these changes were smaller in each sevoflurane group compared with the CON group. See figure 1 for details on groups and statistics.
reperfusion. Indeed, the degree of protection was similar to that found previously for sevoflurane preconditioning. 17, 18, 21 Although there was no memory phase after anesthetic exposure involved in these experiments, i.e., no washout, as in our previous studies, 17, 18, 21 it is likely that the anesthetic activates protective cellular pathways regardless of whether ischemia subsequently occurs. We speculate that the small sevoflurane-induced decrease in metabolic rate, without a change in O 2 delivery, metabolically triggers a protective mechanism mediated by a change in mitochondrial energetics, e.g., a small decrease in mitochondrial Ca 2ϩ , an increase in reduced nicotinamide adenine dinucleotide (NADH), or a small release of O 2 -derived free radicals. 29 Because we could not statistically differentiate effects of the three sevoflurane treatments on reducing Ca 2ϩ loading during ischemia and reperfusion, we suggest that the reduction in Ca 2ϩ loading is a consequence rather than a cause of improved function after sevoflurane treatment.
The immediate period of reperfusion sets the stage for Ca 2ϩ overload 2-7 and a large release of reactive O 2 30, 31 species that leads to mitochondrial and cellular injury and demise. In a preliminary study 31 using a protocol identical to the SBI group, we found that sevoflurane pretreatment reduced peroxynitrite fluorescence in the effluent by 77%. Because peroxynitrite is the product of two free radicals, superoxide and nitric oxide, the reduced release of one or both of these species after ischemia is likely associated with the reduced Ca 2ϩ overloading we observed. This suggests that sevoflurane pretreatment triggers a sequence of events to protect the heart by reducing free radical damage and Ca 2ϩ loading. It is noteworthy that not only was sevoflurane administered before ischemia more protective than when administered on initial reperfusion, but there was also no additive protective effect when sevoflurane was administered both before and after ischemia. Also, postischemic sevoflurane treatment did not seem to suppress metabolism or function compared with sevoflurane pretreatment. This suggests that sevoflurane initiates a maximal protective effect before ischemia that overrides a lesser protective effect elicited by sevoflurane on reperfusion. A major effector of both preischemic and postischemic sevoflurane was reduced Ca 2ϩ loading; combining these protocols also did not additively reduce Ca 2ϩ loading. As in anesthetic preconditioning, the more favorable outcome was garnered if the anesthetic was administered before ischemia.
Role of Cations in Ischemia and Reperfusion Injury
Postischemic reperfusion injury results in large part from mitochondrial 6 -8 and myoplasmic Ca 2ϩ overloading. [2] [3] [4] [5] [6] 21, 25 If the increase in [Ca 2ϩ ] is prolonged, a cascade of events is initiated, which ultimately results in lethal injury. 1, 15 We have recently detailed the time course of changes in contractility and relaxation associated with altered [Na ϩ ], myoplasmic and mitochondrial [Ca 2ϩ ], and [NADH] during reperfusion injury in the intact heart. 6 It was apparent that contractile performance becomes dissociated from myoplasmic Ca 2ϩ , particularly during early reperfusion, in that higher Ca 2ϩ concentrations are associated with reduced contractile force and impaired relaxation. Moreover, the increased [Na ϩ ] and mitochondrial [Ca 2ϩ ] during and after ischemia probably underlies contractile dysfunction. Because Ca 2ϩ loading was temporally associated with Na ϩ loading during early reperfusion 6, 25 and because [Na ϩ ] and [Ca 2ϩ ] were reduced after blocking Na ϩ -H ϩ exchange, 25 our studies strongly support the notion that Na ϩ -H ϩ exchange and reverse Na ϩ -Ca ϩ exchange are major cationic factors that underlie reperfusion injury.
Anesthetic-induced Cardiac Protection
It is not understood how volatile anesthetics protect the myocardium from reperfusion damage, but the over- all mechanism is likely multifactorial. We reported previously that halothane and isoflurane improve function and metabolism on reperfusion and reduce dysrhythmia development when administered 10 min before and after hypoxia 12 or graded or complete global ischemia 13, 14 in isolated guinea pig hearts. Many other studies have supported the cardiac protective effects of anesthetics. 10,11,16 -21,23 We showed that halothane protects against dysrhythmias and improves mechanical, metabolic, and vascular endothelial function when administered during low-flow perfusion for 1 day at 3°C. 23 Isoflurane administered for 45 min before and during 15 min of coronary occlusion in dogs enhanced recovery of regional myocardial contractile function after 5 h of reperfusion. 32 Because this effect was partially blocked by glibenclamide, a role for isoflurane to enhance K ATP channel activation during ischemia and reperfusion was suggested.
Preconditioning by isoflurane, 16,19,33 enflurane, 16 and halothane 16 reduced infarct size in rabbit hearts; the protection was similar to that of ischemic preconditioning. In dogs, isoflurane administered alone or during four 5-min occlusions before 60 min of regional myocardial ischemia reduced infarct size. 20 Because the protective effect was reversed by glibenclamide, this again supported a role for K ATP channel opening. Anesthetics may activate A 1 receptors or increase the sensitivity of adenosine A 1 receptors to attenuated adenosine release. 34 In turn, anesthetic-induced increases in protein kinase C activity may underlie reduced infarct size 33 and improved contractility 35 after ischemia.
We reported that anesthetic preconditioning (APC) with sevoflurane is as effective as ischemic preconditioning (IPC) in improving not only mechanical function, but also cardiac rhythm, perfusion, metabolic function, and basal-and nitric oxide-mediated coronary flow. 18 Moreover, the vascular and myocardial protective effects of APC by sevoflurane and IPC were antagonized by glibenclamide, suggesting a common final mechanism via activation of K ATP channels. In a recent study, we showed that equivalent improvements in metabolic and contractile functions after IPC and APC by sevoflurane were accompanied by equivalent reductions in Ca 2ϩ loading on reperfusion after global ischemia. 21 If K ATP channel antagonism also reverses the reduced Ca 2ϩ loading effects of IPC and APC, this would suggest that cardioprotection is afforded, at least in part, by reduced Ca 2ϩ loading when K ATP channels are open. Interestingly, both APC and IPC reduce cytosolic Ca 2ϩ loading and protect hearts via K ATP channel opening. It is widely believed that IPC activates protein kinase C and tyrosine kinase pathways that in turn promote phosphorylation of sarcolemmal and mitochondrial K ATP channels. 36 -38 It seems clear that APC and IPC lead to protective effects via a common final mechanism that opens K ATP channels and reduces cytosolic Ca 2ϩ loading.
In contrast to APC or anesthetic pretreatment, anesthetic treatment on reperfusion was not quite as protective. It is possible that anesthetic pretreatment triggers a powerful protective effect, as good as IPC, 21 and that anesthetic posttreatment is insufficient to reduce the metabolic rate with the onset of reperfusion. Indeed, sevoflurane administered immediately on reperfusion did not seem to reduce function or metabolism compared with the control group. However, because Ca 2ϩ loading during reperfusion was reduced by sevoflurane administered during reperfusion, the improvement in Ca 38 homeostasis and function is likely linked through an anesthetic-induced effect.
Volatile anesthetics are often selected for patients with coronary artery disease who are at risk for ischemia and infarction during cardiac and noncardiac surgery. Temporary ischemia is often induced during cardiac surgery and angioplasty. 39 A volatile anesthetic may be a safe and efficacious method to protect the heart during cardiac and noncardiac procedures in patients with coronary artery disease. 40 In this study, we investigated possible differences in protective mechanisms when the anesthetic was administered before versus after ischemia and showed that similarly reduced Ca 2ϩ loading contributes to, or results from, both treatment protocols. Further research will seek to determine whether improved cardiac function and Ca 2ϩ homeostasis on reperfusion after anesthetic pretreatment results from factors mediated by intracellular signaling pathways that lead to early activation of K ATP channel opening during the treatment. Future studies will also be directed to determine whether improved function and Ca 2ϩ homeostasis after anesthetic posttreatment is a consequence of enhanced K ATP channel opening on reperfusion.
Possible Limitations
(1) Our studies in the guinea pig may not be easily compared with those of other species, especially the rat. Ischemia in rats causes a marked contracture beginning early during ischemia that is accompanied by a marked increase in diastolic [Ca 2ϩ ] (Stowe et al., laboratory observations, July 1999); on early reperfusion, diastolic LVP remains increased, and diastolic [Ca 2ϩ ] does not increase further. (2) It is possible but unlikely that a portion of the 150-nM increase in diastolic [Ca 2ϩ ] that we found in each group on initial reperfusion was derived from washout of indo-1-bound Ca 2ϩ rather than from cytosolic Ca 2ϩ . Subepicardial left ventricular tissue at the location of the fiberoptic probe was not infarcted but was likely stunned. Because it is phasic, systolic-diastolic [Ca 2ϩ ] must represent cytosolic [Ca 2ϩ ]. (3) It is not possible to separate mitochondrial compartment Ca 2ϩ from other compartments, e.g., nuclear or Ca 2ϩ from other cells, i.e., endothelial, vascular, or nerve. The flux of Ca 2ϩ through each of these compartments is likely very slow. These compartments likely contribute little to the total rapid phasic signal of the myoplasm. We estimated average noncytosolic Ca 2ϩ from MnCl 2 quenching at the end of each experiment, and Mn 2ϩ may leak into this compartment over time. We assumed that the residual fluorescence recorded after quenching cytosolic fluorescence arises predominantly from mitochondrial Ca 2ϩ , but this may be an overestimate. (4) Our study required a crystalloid perfusate devoid of cells with a high O 2 tension, so our findings may not exactly mimic those in blood-perfused hearts. (5) Our study was limited to one concentration of one anesthetic.
